Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (20931)	5/16/1998 2:14:00 PM
From: celeryroot.com	Read Replies (3) \| Respond to of 32384

Who is going to Shareholders meeting???? was thinking of but I'm afraid they might delay it >)

To: Alper H.YUKSEL who wrote (20931)	5/16/1998 2:32:00 PM
From: John O'Neill	Read Replies (1) \| Respond to of 32384

LGND release this on May 15..has it already changed to end of quarter? after 1 day? During the first quarter of 1998, Ligand made important progress in all of its leading drug candidates. Ligand reported positive final results of pivotal international Phase III trials for Panretin(TM) Gel and plans to file a New Drug Application (NDA) by the end of May are on schedule. Panretin(TM) Capsules also demonstrated positive results in two Phase II trials for Kaposi's sarcoma. JO